NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
12/05/2024
Back to search
Official data from USPTO
ELEVATING CLINICAL PERFORMANCE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ELEVATING CLINICAL PERFORMANCE
ST13
US500000086416049Class
44
Filing
86416049
Registration
4766046
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
12/05/2024
Trademark type
Word
Nice classes
44
Filing date
10/06/2014
Registration date
06/30/2015
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/05/2024
Last transaction
12/05/2024
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
03/01/2015
First use in commerce
03/01/2015
Drawing code
4
Owner type
16
Owner location
Saint Louis, MO, US
Examiner
GRIFFIN, JAMES
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
G. P. (pessoa física)
Representatives
Generation Clinical Partners
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Medical services to patients
Publications
History of USPTO decisions and trademark events.
31 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
12/05/2024
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
12/05/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/05/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
08/30/2024
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
06/30/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02/01/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/01/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
02/01/2023
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
12/04/2020
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
12/04/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/10/2020
ES8R
TEAS SECTION 8 RECEIVED
08/14/2020
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06/30/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
06/30/2015
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
05/28/2015
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05/27/2015
SUPC
STATEMENT OF USE PROCESSING COMPLETE
05/17/2015
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
05/17/2015
IUAF
USE AMENDMENT FILED
04/15/2015
EISU
TEAS STATEMENT OF USE RECEIVED
04/15/2015
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
03/31/2015
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/03/2015
PUBO
PUBLISHED FOR OPPOSITION
02/03/2015
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/27/2015
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/27/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/14/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/18/2014
DOCK
ASSIGNED TO EXAMINER
12/18/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/11/2014
NWAP
NEW APPLICATION ENTERED
10/09/2014
Continuous trademark protection
Get notified about every new filing that threatens ELEVATING CLINICAL PERFORMANCE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.